Expand DXR Menu
DXR MENU

DXR Latest Press Releases

-- April 16, 2024 --

New Studies Prove the Clinical Benefits of Daxor's Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of Congestion Globe Newswire 8:00 AM

-- April 15, 2024 --

DAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE SPRING'24 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR'S BLOOD VOLUME DIAGNOSTIC (BVA-100 ) Globe Newswire 8:00 AM

-- April 10, 2024 --

Daxor Corporation Announces New Hospital Account at Leading Chicago Hospital Globe Newswire 8:00 AM

-- April 1, 2024 --

Daxor Corporation to Exhibit at the American College of Cardiology for ACC.24 Globe Newswire 8:00 AM

-- March 25, 2024 --

Daxor Corporation Acquires Volumex and Megatope From Its Existing Supplier Along With Glofil to Enhance Existing Suite of Diagnostics Globe Newswire 8:00 AM

-- March 22, 2024 --

Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024 Globe Newswire 8:00 AM

-- March 18, 2024 --

Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders Globe Newswire 2:18 PM
Daxor Corporation Reports Increase in NAV to $7.08 Per Share and 31.8 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023 Globe Newswire 2:18 PM

-- March 11, 2024 --

Daxor Announces Sales to Three New Hospitals Furthering Expansion of Its User Base Globe Newswire 8:00 AM

-- March 8, 2024 --

Multi-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxor's Unique Clinical Utility for Heart Failure Patients Globe Newswire 8:00 AM

-- February 26, 2024 --

Daxor Corporation to Exhibit at the Technology and Heart Failure Therapeutics Conference Globe Newswire 8:00 AM

-- February 12, 2024 --

Daxor Corporation Starts 2024 with Ongoing Growth in New Blood Volume Analyzer Acquisitions Globe Newswire 8:00 AM

-- February 7, 2024 --

Daxor Corporation Closes Q4 2023 with Growth in New Sales to Hospital Systems and Increased Utilization of its BVA-100 Blood Volume Diagnostic Across the U.S. at Existing Accounts Globe Newswire 8:00 AM

-- January 29, 2024 --

Daxor Corporation to Exhibit at the Society of Nuclear Medicine and Molecular Imaging Mid-Winter and American College Nuclear Medicine Annual Meeting Globe Newswire 8:00 AM

-- January 16, 2024 --

Daxor Corporation to Exhibit at the Society for Critical Care Medicine 2024 Critical Care Congress Globe Newswire 8:00 AM

-- January 9, 2024 --

DAXOR AWARDED ADDITIONAL NEW PATENT FOR SMART BLOOD VOLUME GUIDANCE TECHNOLOGY TO IMPROVE TREATMENT AND OUTCOMES Globe Newswire 8:00 AM

-- January 2, 2024 --

Daxor Corporation Submits Dual 510(k)/CLIA-waiver Application to the FDA for Its Advanced Next-Generation Blood Volume Analyzer Globe Newswire 8:30 AM